Newsletters
2022 Newsletters - 2022-04-04
Non-invasive prenatal screening (NIPS)
Non-invasive prenatal screening (NIPS) is the most sensitive and specific screening test for the common foetal aneuploidies. Due to advances in genomic technologies, we can detect the presence of foetal cell-free DNA, derived from the placenta, circulating in the maternal blood to screen for common foetal aneuploidies. The preferred nomenclature changed from NIPT to NIPS ('S' for screening) to emphasise that utilising a cell-free DNA approach is a screening test and not diagnostic.
Read more2022 Newsletters - 2022-04-04
Update on Malaria
Malaria is a CATEGORY 1 NOTIFIABLE CONDITION according to the National Department of Health's (NDOH)Notifiable Medical Conditions (NMC) list.
Read more2022 Newsletters - 2022-04-04
Updates in the Diagnosis of Meningitis and Encephalitis
Meningitis presents with some combination of neck stiffness, fever, headache, nausea, vomiting and photophobia. Encephalitis is distinguished from meningitis by the presence of abnormal brain function as evidenced by altered mental status, motor or sensory deficits, altered behaviour or personality changes, and speech or movement disorders.
Read more2021 Newsletters - 2021-11-10
World Antimicrobial Awareness
Every year, World Antimicrobial Awareness Week aims to increase awareness of global antimicrobial resistance (AMR) and to encourage best practices among the general public, healthcare workers, and policymakers, to stop the further emergence and spread of drugresistant infections.
Read more